• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Neurologica, Analogic bury the hatchet

Neurologica, Analogic bury the hatchet

September 8, 2011 By MassDevice staff

Analogic, NeuroLogica

NeuroLogica Corp. and its sister firm, medical imaging giant Analogic Corp. (NSDQ:ALOG), buried the hatchet yesterday, settling a lawsuit accusing Analogic of interfering with NeuroLogica’s acquisitions.

The companies are related by dint of being founded by Bernard Gordon, who’s chairman of NeuroLogica and chairman emeritus at Analogic.

"Analogic’s allegations and investigations have been terminated and each party has released the other from all legal claims in accordance with a confidential, mutually-agreeable settlement," according to a prepared statement from NeuroLogica attributed to Gordon.

Sign up to get our free newsletters delivered right to your inbox

Analogic spokesman Mark Namaroff told MassDevice that the company is waiting to issue a formal statement until after the case is officially dismissed.

"Our concerns that were previously raised were resolved," Namaroff told us. "The matter has been settled to our satisfaction and we’re going to leave it at that."

In the lawsuit, filed in the U.S. District Court for Massachusetts, NeuroLogica and co-plaintiffs Gordon and two other NeuroLogica executives accused Analogic of seeking to prevent another, un-named company from acquiring NeuroLogica in a bid to force a below-market buyout in its own favor.

The dispute began last summer, when Peabody, Mass.-based NeuroLogica hired an investment bank to broker a sale. Analogic got wind of “the efforts of various competing entities” to buy NeuroLogica, according to court documents, and “announced that it was ‘investigating’ a diverse range of unlawful conduct allegedly committed by NeuroLogica and its senior officers and directors.”

"For several months, NeuroLogica responded to various Analogic inquiries and shared voluntarily with Analogic a constellation of materials (including various Analogic public securities filings and Analogic board meeting minutes and notes) which conclusively dispute Analogic’s allegations," according to the documents. "Undissuaded, Analogic continued its ‘investigation,’ culminating in the recent assertion that Analogic should purchase NeuroLogica at a substantial ‘discount’ due to NeuroLogica’s alleged legal violations. Alternatively, Analogic demanded that NeuroLogica pay millions of dollars to Analogic, and grant to Analogic a substantial part of any consideration paid upon the sale of NeuroLogica."

Calling the lawsuit threat a "pretext," the plaintiffs claimed that the strategy "has successfully frozen NeuroLogica’s effort to sell the company."

"When NeuroLogica disclosed to its intended acquirer Analogic’s threat of high-stakes litigation against the company and its senior executives, the acquirer refused to go forward with the agreed-upon transaction – thus causing enormous financial damage to NeuroLogica and its shareholders."

Analogic said it raised its concerns that "its intellectual property and other rights had been violated" with NeuroLogica before the lawsuit was filed.

"Analogic believes that NeuroLogica has violated Analogic’s rights and that the lawsuit is completely without merit," according to a press release issued at the time.

The lawsuit sought a jury trial, damages, interest, legal fees and triple damages for willful misconduct.

Filed Under: Legal News, News Well Tagged With: Analogic, NeuroLogica Corp.

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy